newsfilter
← Latest News
PR Newswire·

Leap Therapeutics Presents Final Data from DeFianCe Study at ESMO 2025

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced final ...